Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Aug 30, 2013 (13 years ago)

Aminosyn II

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Confirmed customer complaint of particulate matter, identified as a human hair, visible in the injection port and primary container.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Aminosyn II, 10%, Sulfite-Free Amino Acid Injection, 500 mL container, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4164-03, UPC (01) 0 030409 416403 8.

Affected NDC 0409-4164-03

Compare with the code on your package — it is the most precise check available.

Recalling firm
Hospira Inc.
NDC code
0409-4164-03
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-461-2014 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Hospira Inc.

All 2013 recalls
Class II · Moderate risk

DOBUTamine Injection

Discoloration: Firm received complaints of product discoloration and particulates.

Terminated Failed specification Hospira Inc. NDC 0409-2025-20 D-1500-2016

Other particulate / foreign matter recalls from 2013

All particulate / foreign matter recalls
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

Terminated Particulate / foreign matter Watson Laboratories Inc NDC 0591-5513-05 D-397-2014
Class I · High risk

Lidocaine HCl Injection

Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2066-05 D-1278-2014
Class II · Moderate risk

Propofol Injectible Emulsion

Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1033-2014
Class II · Moderate risk

Carisoprodol IV

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.

Terminated Particulate / foreign matter Physicians Total Care, Inc. D-390-2014